Biopharma Reports Fifth Quarter of Increased Net Revenues
15 Mai 2023 - 5:40PM
AllPennyStocks.com
Those afflicted with sickle cell disease face many challenges
and acute complications. This biopharma company is the leader in
treatment of the disease and just reported its fifth straight
increase...
To read the full story on AllPennyStocks.com, click
here.
Emmaus Life Sciences (NASDAQ:EMMA)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Emmaus Life Sciences (NASDAQ:EMMA)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
